We are live on ! Find out more
CP

Covenant Partners Portfolio holdings

AUM $342M
1-Year Est. Return 19.24%
This Fund
S&P 500
This Quarter Est. Return
+7.01%
1 Year Est. Return
+19.24%
3 Year Est. Return
+70.32%
5 Year Est. Return
+79.29%
10 Year Est. Return
AUM
$353M
AUM Growth
+$17.7M
Cap. Flow
-$3.98M
Cap. Flow %
-1.13%
Top 10 Hldgs %
75.02%
Holding
150
New
4
Increased
17
Reduced
12
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 8.55%
2 Financials 5.97%
3 Healthcare 3.24%
4 Consumer Discretionary 3.24%
5 Industrials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CP icon
26
Canadian Pacific Kansas City
CP
$82B
$1.53M 0.43%
20,591
NFLX icon
27
Netflix
NFLX
$292B
$1.52M 0.43%
12,690
BLK icon
28
Blackrock
BLK
$164B
$1.47M 0.42%
1,264
ABBV icon
29
AbbVie
ABBV
$458B
$1.47M 0.42%
6,351
CVX icon
30
Chevron
CVX
$388B
$1.42M 0.4%
9,143
+1,704
+23% +$264K
PAYX icon
31
Paychex
PAYX
$40.4B
$1.37M 0.39%
10,822
PANW icon
32
Palo Alto Networks
PANW
$264B
$1.32M 0.37%
6,494
ING icon
33
ING
ING
$93.8B
$1.28M 0.36%
49,131
OAKM
34
Oakmark U.S. Large Cap ETF
OAKM
$1.09B
$1.27M 0.36%
47,270
+19,317
+69% +$507K
GWW icon
35
W.W. Grainger
GWW
$65.3B
$1.24M 0.35%
1,302
SE icon
36
Sea Limited
SE
$61.2B
$1.16M 0.33%
6,487
STE icon
37
Steris
STE
$20.9B
$1.14M 0.32%
4,598
ABT icon
38
Abbott
ABT
$180B
$1.11M 0.31%
8,267
COF icon
39
Capital One
COF
$124B
$1.03M 0.29%
4,866
NVS icon
40
Novartis
NVS
$295B
$967K 0.27%
7,542
PHG icon
41
Philips
PHG
$25.4B
$945K 0.27%
35,939
RELX icon
42
RELX
RELX
$60.1B
$912K 0.26%
19,100
JNK icon
43
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.24B
$897K 0.25%
9,158
+299
+3% +$29K
RJF icon
44
Raymond James Financial
RJF
$32.5B
$879K 0.25%
5,093
AON icon
45
Aon
AON
$77.3B
$875K 0.25%
2,454
FERG icon
46
Ferguson
FERG
$44.7B
$852K 0.24%
3,795
ETN icon
47
Eaton
ETN
$157B
$806K 0.23%
2,154
SPGI icon
48
S&P Global
SPGI
$126B
$769K 0.22%
1,581
FLEX icon
49
Flex
FLEX
$43.4B
$721K 0.2%
12,434
SPOT icon
50
Spotify
SPOT
$99.2B
$715K 0.2%
1,025

Similar funds

Covenant Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Covenant Partners held 150 positions worth $353M, up 5.3% from $335M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Covenant Partners's Q3 2025 filing shows 4 new, 17 increased, 12 reduced and 15 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 604 shares worth $275K. The largest sale was iShares Russell 2000 Value ETF, an estimated $1.62M.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 8.9% a quarter earlier, followed by Financials and Healthcare.

  • Covenant Partners's largest Q3 2025 buy was Alnylam Pharmaceuticals: 604 shares worth $275K.
  • Covenant Partners added most to iShares Russell 1000 Growth ETF in Q3 2025, an estimated $1.6M increase.
  • Covenant Partners's biggest Q3 2025 reduction was iShares Russell 2000 Value ETF, cutting an estimated $1.62M.
  • Covenant Partners fully exited UnitedHealth in Q3 2025, selling an estimated $679K.
  • Covenant Partners's ten largest holdings make up 75% of its $353M portfolio in Q3 2025.
  • Covenant Partners opened 4 new positions and closed 15 in Q3 2025.
  • Covenant Partners's portfolio value rose 5.3% quarter-over-quarter to $353M.

Based on Covenant Partners's 13F filing for Q3 2025, filed 24 Oct 2025.